Currencies / BMRN
BMRN: BioMarin Pharmaceutical Inc
55.91
USD
1.41
(2.59%)
BMRN exchange rate has changed by 2.59% for today. During the day, the instrument was traded at a low of 54.20 and at a high of 55.94.
Follow BioMarin Pharmaceutical Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BMRN News
- Biomarin at Morgan Stanley Conference: Strategic Growth and Innovation
- Are Options Traders Betting on a Big Move in BioMarin Pharmaceutical Stock?
- PTC Therapeutics To Challenge BioMarin's Metabolic Disorder Treatment - BioMarin Pharmaceutical (NASDAQ:BMRN)
- This Duolingo Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Bullish (NYSE:BLSH), BioMarin Pharmaceutical (NASDAQ:BMRN)
- BioMarin’s PKU drug shows nearly 50% blood Phe reduction in teens
- BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound?
- BioMarin Pharmaceutical Inc. (BMRN) Presents at Cantor Global Healthcare Conference 2025
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
- BioMarin stock rating reiterated at Outperform by Oppenheimer on Voxzogo strength
- BioMarin stock price target raised to $95 by Bernstein following Inozyme acquisition
- BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?
- Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
- Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
- BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030 - BioMarin Pharmaceutical (NASDAQ:BMRN)
- BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View
- 3 Best Stocks to Buy Now, 8/5/2025, According to Top Analysts - TipRanks.com
- BioMarin Pharmaceutical Inc. (BMRN) Q2 2025 Earnings Call Transcript
- BioMarin (BMRN) Q2 Revenue Jumps 16%
- BioMarin (BMRN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- BioMarin (BMRN) Q2 2025 Earnings Call Transcript
- Earnings call transcript: Biomarin beats Q2 2025 estimates, stock rises
- BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates
- After-hours movers: Palantir, Hims & Hers, Vertex Pharma and more
Daily Range
54.20
55.94
Year Range
52.94
73.51
- Previous Close
- 54.50
- Open
- 54.46
- Bid
- 55.91
- Ask
- 56.21
- Low
- 54.20
- High
- 55.94
- Volume
- 4.773 K
- Daily Change
- 2.59%
- Month Change
- -4.26%
- 6 Months Change
- -20.36%
- Year Change
- -20.50%
11 September, Thursday
08:00
ALL
- Act
- Fcst
- Prev
11:00
ALL
- Act
- Fcst
- Prev
12:30
USD
- Act
- Fcst
- 0.2%
- Prev
- 0.2%
12:30
USD
- Act
- Fcst
- 0.3%
- Prev
- 0.3%
12:30
USD
- Act
- Fcst
- 2.9%
- Prev
- 2.7%
12:30
USD
- Act
- Fcst
- 3.3%
- Prev
- 3.1%
12:30
USD
- Act
- Fcst
- Prev
- 0.2%
12:30
USD
- Act
- Fcst
- 322.956
- Prev
- 322.132
12:30
USD
- Act
- 263 K
- Fcst
- 235 K
- Prev
- 236 K
12:30
USD
- Act
- 1.939 M
- Fcst
- 1.923 M
- Prev
- 1.939 M
17:00
USD
- Act
- 4.651%
- Fcst
- Prev
- 4.813%
18:00
USD
- Act
- $-344.8 B
- Fcst
- $-283.5 B
- Prev
- $-291.1 B